Another 26 are associated with diseases having connective tissue dysplasia symptoms (red print in Table S3 column J), including particularly the NLRP3 gene that, like LIFR, is relevant to both EDS and COVID-19 severity (Figure 3). This evidence concerns the gene LIFR and COVID-19.